Protection from an overwhelming immune response in COVID-19 is critical for patient survival and the regulation of inflammatory factors, like IL-8, ROS, or CXCL10 by CLEC12A might play an important functional role, besides its utility as a biomarker for outcome prediction in critically ill COVID-19 patients. This evidence concerns the gene CXCL10 and COVID-19.